2020
DOI: 10.1016/bs.pmbts.2020.08.006
|View full text |Cite
|
Sign up to set email alerts
|

Strain variation in treatment and prevention of human prion diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 124 publications
0
5
0
Order By: Relevance
“…This amount is representative of real-life conditions, taking into consideration that the liquid waste we aimed to simulate generally contains only a small fraction of infectious material [32]. Since it is possible that prion strain variation may influence the efficacy of treatment approaches [33], the results of this study apply to RML prion strain in mice and cannot be easily adapted to every prion strain. Yet, in a recent study [34], it was proposed that the efficiency of each inactivation method should be proven for each prion strain against which it is intended to be used.…”
Section: Discussionmentioning
confidence: 99%
“…This amount is representative of real-life conditions, taking into consideration that the liquid waste we aimed to simulate generally contains only a small fraction of infectious material [32]. Since it is possible that prion strain variation may influence the efficacy of treatment approaches [33], the results of this study apply to RML prion strain in mice and cannot be easily adapted to every prion strain. Yet, in a recent study [34], it was proposed that the efficiency of each inactivation method should be proven for each prion strain against which it is intended to be used.…”
Section: Discussionmentioning
confidence: 99%
“…The effectiveness of prion decontaminants can also depend on the prion strain type [ 12 , 25 , 42 , 44 , 48 , 60 , 61 ]. Due to the scarcity of suitable human prion mouse models [ 62 , 63 ], we relied on the rodent-adapted prion strain, RML6, which has been widely used as a model strain for the development and validation of prion decontaminants (Fichet, Comoy et al 2004, Lemmer, Mielke et al 2008, Edgeworth, Sicilia et al 2011, McDonnell, Dehen et al 2013).…”
Section: Discussionmentioning
confidence: 99%
“…At the interindividual scale, it defines the prion strain or prion field isolate. The extent of this diversity at least equals the number of prion strains identified thus far [8, 33, 34]. At the strain scale, the structural diversity reflects the coexistence of PrP Sc subpopulations (or substrain conformers) [23, 26].…”
Section: Discussionmentioning
confidence: 99%
“…Such unicity inevitably allows us to conclude that the strain information is not defined by the size of the PrP Sc elementary brick as we previously hypothesized [35] but is defined by the conformation of this dimer. However, considering the growing number of prion strains (considering natural and experimental strains roughly close to 50 [8, 25, 33, 34]), it is not trivial to imagine how such diversity could be encoded in a commune dimeric quaternary structure in a stable manner during multiple replication events without affecting the stability of the oligomerization interface. Such a thermodynamic paradox can be circumvented if the oligomerization domain (i.e., dimerization interface) is structurally independent from the domain encoding the strain information.…”
Section: Discussionmentioning
confidence: 99%